Stop defining CX (just) as an outcome
I am honest. Sometimes I am seriously bothered. Bothered by the capriciousness, I see the “CX” label been used from time to time. I am… Read more »Stop defining CX (just) as an outcome
I am honest. Sometimes I am seriously bothered. Bothered by the capriciousness, I see the “CX” label been used from time to time. I am… Read more »Stop defining CX (just) as an outcome
In case you have no background in this industry, you might be surprised to hear that in pharma we actually have two different customer engaging… Read more »Overcoming the schism in pharma customer engagement
I am looking forward to being challenged by Mark Doyle on the “the patient = the customer” paradigm I am always advocating for. Listen to… Read more »Mark Doyle challenging me on “the patient = the customer”
I am proudly looking forward to joining Margot O’Neil from GSK and Dirk Abeel from OMNI-X-ELLERATION for a panel discussion about the current maturity of… Read more »Omnichannel transformation: job well done?! @ NEXT Pharma Summit 2022
I am frequently asked about the difference between “multi-channel” and “omnichannel”. And typically my nutshell-answer is … ‘multi-channel’ provides you an increased toolbox of channels… Read more »What is the difference between multi-channel and omnichannel?
Honestly spoken, I had been very much surprised by this statement by Amazon-founder Jeff Bezos‘ as Amazon is known as such a strong data-driven and… Read more »Taking anecdotal feedback serious
MAPS Switzerland/nordics Chapter launch event “The power of digital in medical affairs” on December 16th 2021
I am looking forward to representing Roche and speaking at the “2nd Annual CX Management for Life Science” conference, taking place 9th/10th of December 2021.… Read more »Meet me @CX for Life Science virtual conference on Dec 9/10
OK, honestly spoken, I am afraid to say that when it comes to customer portals I might be biased. Over the past decades, I have… Read more »Does your customer portal meet customer needs … or yours?
Panel on Modernizing Medical Affairs at the Reuters Pharma 2021 conference